Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Change in Intangibles: 2024-2025

Historic Change in Intangibles for Myriad Genetics (MYGN) over the last 2 years, with Sep 2025 value amounting to $3.4 million.

  • Myriad Genetics' Change in Intangibles rose 21.43% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.3 million, marking a year-over-year change of. This contributed to the annual value of $300,000 for FY2010, which is N/A change from last year.
  • As of Q3 2025, Myriad Genetics' Change in Intangibles stood at $3.4 million, which was down 17.07% from $4.1 million recorded in Q2 2025.
  • Over the past 5 years, Myriad Genetics' Change in Intangibles peaked at $4.1 million during Q2 2025, and registered a low of $1.9 million during Q1 2024.
  • For the 2-year period, Myriad Genetics' Change in Intangibles averaged around $3.1 million, with its median value being $3.2 million (2025).
  • Data for Myriad Genetics' Change in Intangibles shows a peak YoY soared of 57.89% (in 2025) over the last 5 years.
  • Over the past 2 years, Myriad Genetics' Change in Intangibles (Quarterly) stood at $2.8 million in 2024, then grew by 21.43% to $3.4 million in 2025.
  • Its Change in Intangibles was $3.4 million in Q3 2025, compared to $4.1 million in Q2 2025 and $3.0 million in Q1 2025.